InsiderClue
Insiders · Profile

Ridloff Elena

Director at Kymera Therapeutics · CFO & Head of Corp. Dev. at Sionna Therapeutics · EVP and CFO at ACADIA PHARMACEUTICALS. Filing since 9 Dec 2019. CIK 0001772518

KYMR Kymera Therapeutics, Inc. Director · 5 trades SION Sionna Therapeutics, Inc. CFO & Head of Corp. Dev. · 7 trades ACAD ACADIA PHARMACEUTICALS INC EVP and CFO · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR Kymera Therapeutics, Inc.
11 May 2026
Director
Sold on a plan
3,000
$261.00K
100%
KYMR Kymera Therapeutics, Inc.
1 Apr 2026
Director
Sold on a plan
4,600
$392.92K
100%
KYMR Kymera Therapeutics, Inc.
31 Mar 2026
Director
Sold on a plan
7,400
$631.74K
100%
SION Sionna Therapeutics, Inc.
2 Sep 2025
CFO & Head of Corp. Dev.
Sold on a plan
8,836
$221.61K
18.7%
SION Sionna Therapeutics, Inc.
29 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
748
$18.83K
1.6%
SION Sionna Therapeutics, Inc.
28 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
16,098
$418.07K
25.1%
SION Sionna Therapeutics, Inc.
27 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
3,618
$90.81K
5.3%
SION Sionna Therapeutics, Inc.
26 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
3,700
$92.98K
5.2%
SION Sionna Therapeutics, Inc.
20 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
17,500
$397.08K
19.7%
SION Sionna Therapeutics, Inc.
19 Aug 2025
CFO & Head of Corp. Dev.
Sold on a plan
34,500
$727.26K
27.9%
KYMR Kymera Therapeutics, Inc.
11 Jun 2025
Director
Sold on a plan
4,500
$225.00K
100%
KYMR Kymera Therapeutics, Inc.
3 Jun 2025
Director
Sold on a plan
12,000
$553.20K
100%
ACAD ACADIA PHARMACEUTICALS INC
30 Apr 2021
EVP and CFO
Sold, plan not stated
1,032
$20.98K
8.9%
ACAD ACADIA PHARMACEUTICALS INC
4 Feb 2021
EVP and CFO
Sold, plan not stated
2,051
$103.80K
19.7%
ACAD ACADIA PHARMACEUTICALS INC
6 Jan 2021
EVP and CFO
Sold, plan not stated
1,016
$54.19K
20.7%
ACAD ACADIA PHARMACEUTICALS INC
30 Apr 2020
EVP and CFO
Sold, plan not stated
1,050
$51.68K
32.4%
ACAD ACADIA PHARMACEUTICALS INC
29 Apr 2020
EVP and CFO
Sold, plan not stated
10,000
$507.35K
100%
ACAD ACADIA PHARMACEUTICALS INC
9 Dec 2019
EVP and CFO
Sold, plan not stated
36,000
$1.79M
100%
18 decisions on file.